Kythera Files For IPO
socalTECH
MAY 17, 2012
Calabasas-based KYTHERA Biopharmaceuticals , a developer of biopharmaceuticals for the aesthetic medicine market, has filed for an IPO. The firm reported a net loss of $11.1M on license income of $12.98M in 2011. The firm's offering is being underwritten by J.P. Morgan, Goldman, Sachs & Co., READ MORE>>.
Let's personalize your content